Adolescence

Almirall continues its progress to leadership in Medical Dermatology driven by strong growth in the European Dermatology business

Retrieved on: 
Monday, February 19, 2024
Biotechnology, Pharmaceutical, Health, Clinical Trials, Therapy, LNP, Acquisition, European Commission, Psoriasis, Adolescence, Immune system, Messenger, Research and development, Investment, Net, Atopic dermatitis, Growth, Drug discovery, Novo Nordisk, Safety, Human, Significance, Health care, Civil service commission, Skin, Administration, Patient, MHRA, Disease, Phase, Trial of the century, NDA, Medication, Vaccine

Net Sales of €895 MM represented year-on-year growth of 4%, driven by strong performance of the European Dermatology business.

Key Points: 
  • Net Sales of €895 MM represented year-on-year growth of 4%, driven by strong performance of the European Dermatology business.
  • Powered by our dedicated investments in launches and innovation, we achieved a 4% year-on-year growth in Net Sales, accounting for €895 MM, which was mainly driven by our European dermatology business.
  • Almirall has complemented its exciting pipeline and discovery efforts through strategic partnerships, adding long-term value to its medical dermatology portfolio.
  • The strategic focus on medical dermatology has positioned the company well for sustained growth and leadership in the medium term and beyond.

UT Health San Antonio secures $16.4 million from CPRIT over six months, adding transformative expertise, bolstering cancer research

Retrieved on: 
Friday, March 8, 2024
Doctor of Philosophy, Education, MD, Drug development, DNA repair, National Cancer Institute, Breast, University, RNA, Research institute, Ovarian cancer, Cell Systems, Health, Genetics, Anatomy, Biochemistry, Bangladesh Technical Education Board, Algorithm, Adolescence, Nursing, Neoplasm, Kitagawa, Faculty, Dentistry, HPV, Child, DNA, Chromatin, Therapy, SAN, National Institutes of Health, Mentorship, Chromosome instability, Doctor of Pharmacy, Structural biology, Vaccination, Cancer Research Institute, Molecular medicine, News, Laboratory, Research, University of Texas System, Cedars-Sinai Medical Center, Survivor, BRCA2, Cell, Howard Hughes Medical Institute, School, Cancer prevention, Luan, BRCA1, Patient, Teaching, Ewing sarcoma, Cancer, Public, Vaccine

SAN ANTONIO, March 7, 2024 /PRNewswire-PRWeb/ -- The University of Texas Health Science Center at San Antonio (UT Health San Antonio) (https://uthscsa.edu/) has secured approximately $16.4 million in funding from the Cancer Prevention and Research Institute of Texas (https://www.cprit.state.tx.us/about-us) the past six months, attracting three top cancer researchers and advancing child and adolescent cancer research.

Key Points: 
  • SAN ANTONIO, March 7, 2024 /PRNewswire-PRWeb/ -- The University of Texas Health Science Center at San Antonio (UT Health San Antonio) ( https://uthscsa.edu/ ) has secured approximately $16.4 million in funding from the Cancer Prevention and Research Institute of Texas ( https://www.cprit.state.tx.us/about-us ) the past six months, attracting three top cancer researchers and advancing child and adolescent cancer research.
  • The Mays Cancer Center at UT Health San Antonio ( https://cancer.uthscsa.edu/ ) is one of only four National Cancer Institute-designated Cancer Centers in Texas.
  • The Mays Cancer Center provides leading-edge cancer care, propels innovative cancer research and educates the next generation of leaders to end cancer in South Texas.
  • The Greehey Children's Cancer Research Institute ( https://cancer.uthscsa.edu/gccri ) is one of only two institutes in the United States dedicated solely to pediatric cancer research.

Althing's District AIRs Pioneers the First Self Funded and Scalable Adolescent Health Service

Retrieved on: 
Wednesday, March 6, 2024
Mental health, AIRS, Adolescence, Student, MD, Medical director, Intervention, University, Parent, Risk, Travel, Human, Disability, Leadership Institute, Patient, Privacy, Insurance, Workforce, Face, Partnership, Nursing

AUSTIN, Minn., March 6, 2024 /PRNewswire/ -- Althing's District Assess Intervene Refer & services (AIRs) model is the first statute compliant, whole district behavioral health solution that has proven capable of tackling the youth mental health crisis. Today Althing announces a major breakthrough in scalability and sustainability of vital district health and safety services; through the development of a no-cost model.

Key Points: 
  • AUSTIN, Minn., March 6, 2024 /PRNewswire/ -- Althing's District Assess Intervene Refer & services (AIRs) model is the first statute compliant, whole district behavioral health solution that has proven capable of tackling the youth mental health crisis.
  • The answer must come from a scalable, self sustaining, ubiquitous service.
  • District AIRs is proactive, qualified care that meets reimbursement criteria so that students, parents and districts gain vital health and safety benefits at no cost.
  • Althing's District AIRs is the first, and only program shown capable of addressing the ramping national mental health epidemic at its roots.

Addressing New York's Youth Mental Health Crisis, Montefiore Announces Plans for New Pediatric Inpatient Psychiatry Unit

Retrieved on: 
Wednesday, March 6, 2024
New York State Assembly, Anxiety, Mental health, New Yorker, Adolescence, Suicidal ideation, Education, HRSA, Montefiore Medical Center, Hospital, Bed, Assembly, Mental, JAMA, Psychosis, Behavioural sciences, Depression, Patient, Pediatrics, Child, Psychiatry, Trauma, Environment, Travel, Intensive outpatient program, Nursing

BRONX, N.Y., March 6, 2024 /PRNewswire/ -- Montefiore today announced plans for a new pediatric inpatient psychiatry unit adding a new care option to address the unmet urgent behavioral and mental health needs of children and adolescents in the Bronx. The Montefiore Einstein Center for Children's Mental Health of the Children's Hospital at Montefiore Einstein will be funded in part by a nearly $6 million appropriation to Montefiore spearheaded by New York State Assembly Speaker Carl Heastie and Assembly Member Michael Benedetto. The 21-bed child and adolescent unit will be located within the New York City Children's Center (NYCCC) campus adjacent to the Albert Einstein College of Medicine and will serve as a model for urban pediatric inpatient psychiatric services. The new program will physically and programmatically extend the capacity of CHAM to provide a full range of medical and behavioral health services for youth in the region. The proposed center will be designed to provide best-in-class intensive treatment for youth with serious behavioral health conditions including severe depression, anxiety, trauma, suicidal thoughts, psychosis and other acute psychiatric conditions.

Key Points: 
  • BRONX, N.Y., March 6, 2024 /PRNewswire/ -- Montefiore today announced plans for a new pediatric inpatient psychiatry unit adding a new care option to address the unmet urgent behavioral and mental health needs of children and adolescents in the Bronx.
  • The new program will physically and programmatically extend the capacity of CHAM to provide a full range of medical and behavioral health services for youth in the region.
  • As a leading health system in New York renowned for delivering exceptional care, I am confident that Montefiore will exceed in tackling mental health disparities with the new pediatric psychiatry unit," said New York State Assembly Speaker Carl Heastie.
  • The Montefiore pediatric psychiatry unit will provide 24/7 best-in-class care and access to comprehensive evaluation and care administered by mental health professionals expert in pediatric psychiatry.

Sun Pharma Launches WINLEVI® (clascoterone) Cream 1% Connected TV (CTV) Ad Campaign with Dr. Sandra Lee (a.k.a. "Dr. Pimple Popper")

Retrieved on: 
Wednesday, March 6, 2024
Amazon Prime Video, Social media, Gettin' Ready, Netflix, Marketing, Adolescence, Acne, Smart TV, Connected, Toxicity, Family Dinner, Inflammation, FDA, Gland, Dermatology, Parent, Skin, Itch, Edema, Potassium, Hulu, Stinger, Irritation, Hyperkalemia, Apple TV, CTV, Clascoterone, Patient, Sebaceous gland, Game Night, Diagnosis, Sun Pharma, HPA, Research

WINLEVI is the first and only FDA-approved topical acne treatment available in the U.S. that targets sebum production in the skin.

Key Points: 
  • WINLEVI is the first and only FDA-approved topical acne treatment available in the U.S. that targets sebum production in the skin.
  • "We are thrilled to continue our collaboration with Dr. Sandra Lee, whose persona as 'Dr.
  • Pimple Popper' fits well with our use of humorous and relatable content to connect with teens.
  • Additionally, edema, stinging, and burning occurred in >3% of patients and were reported in a similar percentage of subjects treated with vehicle.

Magellan Health Introduces Digital Cognitive Behavioral Therapy Programs for Children and Adolescents

Retrieved on: 
Tuesday, March 5, 2024
Anxiety, Mental health, COVID-19, Adolescence, Ferdinand Magellan, Cognitive behavioral therapy, Pediatrics, Psychiatry, Magellan Health, Bentham Science Publishers, Pediatrics (journal), American Academy, Nursing

FRISCO, Texas, March 5, 2024 /PRNewswire/ -- Magellan Health, Inc., a leader in behavioral health and related services, today announced two new digital cognitive behavioral therapy (DCBT) programs for children and adolescents struggling with anxiety-related symptoms.

Key Points: 
  • FRISCO, Texas, March 5, 2024 /PRNewswire/ -- Magellan Health, Inc. , a leader in behavioral health and related services, today announced two new digital cognitive behavioral therapy (DCBT) programs for children and adolescents struggling with anxiety-related symptoms.
  • These new programs enhance Magellan's existing evidence-based, award-winning Digital Emotional Wellbeing program, powered by NeuroFlow .
  • These tools also extend the capacity of clinicians to care for children in the primary care space," said Caroline Carney, M.D., president of behavioral health and chief medical officer of Magellan Health.
  • "These new programs demonstrate Magellan's commitment to integrating digital tools within the healthcare experience to help members build thriving lives, resilient minds and healthy bodies."

Gateways Hospital and Mental Health Center Opens New Sensory Room, Providing Vulnerable Clients with Innovative, Client-Centered Care

Retrieved on: 
Friday, March 1, 2024
Gateways, Anxiety, Mental health, Caregiver, Adolescence, Emotion, LOS, Occupational therapy, Hospital, Patient, Sound, Royal college, Sensory room, Employment, Health, Agitation, Lighting, Psychiatry, Self-management, Environment, Nursing

LOS ANGELES, March 1, 2024 /PRNewswire/ -- Gateways Hospital and Mental Health Center unveiled its groundbreaking Sensory Room, a pioneering addition to acute patient care in Los Angeles, generously funded by a $45,000 grant from the Robert Ellis Simon Foundation. This innovative space signifies Gateways' commitment to implementing client-centered approaches, blending the latest inpatient psychiatric care practices with immersive sensory interventions, meaningful activities, and fostering connections between clients and caregivers.

Key Points: 
  • Colleen Carroll, Occupational Therapy Director at Gateways Mental Health Center and Hospital, expressed enthusiasm about the sensory room's impact, stating, "Gateways prioritizes resources that prioritize our clients' well-being.
  • Guided by Gateways' mental health professionals, clients can customize their sensory experiences by adjusting lighting, sound, and tactile elements, granting them autonomy over their care.
  • "This grant empowers us to redefine acute mental health care by providing a safe, engaging experience for our clients," said Dr. Wong.
  • "Gateways' Sensory Room sets a new standard for patient-centered care, aligning with our mission to empower individuals in their mental health journey."

Accolade Welcomes Brightline to Trusted Partner Ecosystem

Retrieved on: 
Tuesday, February 27, 2024
Anxiety, Mental health, Caregiver, Adolescence, American Academy, ACCD, Lyra, Parent, Headspace, Health, Accolade, Nursing care plan, Frustration, Depression, Family, Burnout, ADHD, Psychiatry, Trusted Partner, Equip, Bentham Science Publishers, Partnership, Nursing

SEATTLE, Feb. 27, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today that Brightline, a comprehensive pediatric behavioral health solution built for children, teens, their parents, and caregivers, has joined the company's Trusted Partner Ecosystem. The Brightline partnership builds on Accolade's existing behavioral health partnerships with Headspace, Lyra, and Equip and internal capabilities, including an in-house behavioral health advocacy team, Accolade Care therapists, and consulting psychiatrists.

Key Points: 
  • Partnership expands access to high-quality, affordable adolescent and children's behavioral health services
    SEATTLE, Feb. 27, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today that Brightline, a comprehensive pediatric behavioral health solution built for children, teens, their parents, and caregivers, has joined the company's Trusted Partner Ecosystem.
  • The Brightline partnership builds on Accolade's existing behavioral health partnerships with Headspace, Lyra, and Equip and internal capabilities, including an in-house behavioral health advocacy team, Accolade Care therapists, and consulting psychiatrists.
  • We help them move through the daunting barriers to care access," said Nancy Costlow, Accolade Senior Director, Clinical Shared Services.
  • We are thrilled to partner with Accolade to help drive awareness of Brightline's solution and improve access to a critical benefit that is missing for many families today."

Blue Ridge Eating Disorder Care Center is Now In-Network with Geisinger Health Plan & Highmark Blue Cross Blue Shield Insurance

Retrieved on: 
Thursday, February 22, 2024
Highmark, Woman, Adolescence, OSFED, Freedom, Travel, Eating disorder, ARFID, Patient, Family, Bulimia nervosa, Environment, Insurance, Health insurance

View original content:https://www.prnewswire.com/news-releases/blue-ridge-eating-disorder-care...

Key Points: 
  • SAYLORSBURG, Pa., Feb. 22, 2024 /PRNewswire/ -- Blue Ridge Eating Disorder Care Center has announced that they now offer young women in need of Residential eating disorder care in-network coverage with Geisinger Health Plan and Highmark Blue Cross Blue Shield.
  • Blue Ridge Eating Disorder Care Center's Clinical Director and Founder, Erica Butler, notes, "Eating Disorder treatment can be hard to find, and when you do find a facility that can meet your family's needs, it can be especially challenging to navigate care if they aren't in-network with your insurance provider.
  • We are thrilled to continue to give families access to exceptional eating disorder care without the financial barriers."
  • Blue Ridge Eating Disorder Care Center is an in-network Residential treatment facility for young women ages 12-17 with a primary diagnosis of an eating disorder serving patients in Saylorsburg, Pennsylvania.

Fierce Healthcare Names Talkiatry a "Fierce 15" Company of 2024

Retrieved on: 
Tuesday, February 20, 2024
Anxiety, Adolescence, Bipolar disorder, Cigna, Health care, Medicare, Creativity, Patient, PTSD, Insurance, Child, ADHD, OCD, Face, Depression

NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Talkiatry, a leading provider of high-quality, in-network psychiatric care, announced today that Fierce Healthcare has named it one of 2024's "Fierce 15" healthcare companies. The annual special report features the most innovative private healthcare companies looking to change the face of the industry. 

Key Points: 
  • NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Talkiatry, a leading provider of high-quality, in-network psychiatric care, announced today that Fierce Healthcare has named it one of 2024's "Fierce 15" healthcare companies.
  • The annual special report features the most innovative private healthcare companies looking to change the face of the industry.
  • "It's an honor to be featured in the 'Fierce 15' list with so many other visionary healthcare leaders," said Robert Krayn, co-founder and CEO, Talkiatry.
  • "For the past six years, we have assessed hundreds of private companies for inclusion in the 'Fierce 15' special report.